{"text": ["Novartis", "Expands", "Presence", "in", "Gene", "Therapy", "With", "Acquisition"], "created_at": "2020-11-02 21:33:29"}
{"text": ["Top", "Analyst", "Reports", "for", "PayPal,", "Comcast", "&", "Novartis"], "created_at": "2020-11-02 19:45:07"}
{"text": ["Analyst", "Report:", "Novartis", "AG"], "created_at": "2020-11-02 19:23:49"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Eli", "Lilly,", "Merck,", "Pfizer,", "Novartis,", "AstraZeneca", "and", "J&J"], "created_at": "2020-11-02 18:27:06"}
{"text": ["Novartis", "announces", "positive", "results", "from", "a", "Phase", "IV", "study", "showing", "superior", "tolerability", "and", "efficacy", "of", "Aimovig\u00ae", "(erenumab)", "compared", "with", "topiramate", "in", "migraine", "prevention"], "created_at": "2020-11-02 06:15:00"}
